STORM Therapeutics Awarded Innovate UK Grant to Discover and Develop a Novel Coronavirus Therapy Targeting an RNA-Modifying Enzyme Read more
Genesis Therapeutics Announces Strategic Collaboration with Lilly to Discover Novel Therapies Using the Genesis Molecular AI Platform Read more
Nicoya Completes Acquisition of LSK Technologies, Expanding Digital Platform into Molecular Testing Read more
Endo Acquires Six Development-Stage, Ready-to-Use Injectable Product Candidates From Nevakar Read more
Horizon Therapeutics plc Receives European Commission (EC) Approval of UPLIZNA (inebilizumab) for the Treatment of Adults With Neuromyelitis Optica Spectrum Disorder (NMOSD) Read more
Intravacc signs an exclusive license agreement with Zhifei Lvzhu Biopharmaceutical to commercialize Avacc 3 – an OMV based whooping cough vaccine Read more
RINVOQ (upadacitinib) Approved by FDA as an Oral Treatment for Adults with Active Ankylosing Spondylitis Read more
GC Biopharma Concludes Agreement With Acuitas Therapeutics for Lipid Nanoparticle Delivery System for Use in mRNA Vaccines and Therapeutics Read more